These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32045666)

  • 1. Targeting obesity with plant-derived pancreatic lipase inhibitors: A comprehensive review.
    Rajan L; Palaniswamy D; Mohankumar SK
    Pharmacol Res; 2020 May; 155():104681. PubMed ID: 32045666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kojic acid repurposing as a pancreatic lipase inhibitor and the optimization of its production from a local Aspergillus oryzae soil isolate.
    El-Korany SM; Helmy OM; El-Halawany AM; Ragab YE; Zedan HH
    BMC Biotechnol; 2020 Oct; 20(1):52. PubMed ID: 33008398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiobesity potential of ursolic acid stearoyl glucoside by inhibiting pancreatic lipase.
    Kazmi I; Afzal M; Rahman S; Iqbal M; Imam F; Anwar F
    Eur J Pharmacol; 2013 Jun; 709(1-3):28-36. PubMed ID: 23500199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyphenolic Compounds as Pancreatic Lipase Inhibitors.
    Buchholz T; Melzig MF
    Planta Med; 2015 Jul; 81(10):771-83. PubMed ID: 26132857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of Korean medicinal plants for lipase inhibitory activity.
    Kim HY; Kang MH
    Phytother Res; 2005 Apr; 19(4):359-61. PubMed ID: 16041737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural inhibitors of pancreatic lipase as new players in obesity treatment.
    de la Garza AL; Milagro FI; Boque N; Campión J; Martínez JA
    Planta Med; 2011 May; 77(8):773-85. PubMed ID: 21412692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipase Inhibitors for Obesity: A Review.
    Liu TT; Liu XT; Chen QX; Shi Y
    Biomed Pharmacother; 2020 Aug; 128():110314. PubMed ID: 32485574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible anti-obesity therapeutics from nature--a review.
    Yun JW
    Phytochemistry; 2010 Oct; 71(14-15):1625-41. PubMed ID: 20732701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of pancreatic lipase.
    Blackburn GL
    Am J Clin Nutr; 2000 Mar; 71(3):845-6. PubMed ID: 10702184
    [No Abstract]   [Full Text] [Related]  

  • 10. More about orlistat.
    Lucas KH; Kaplan-Machlis B
    Pharmacotherapy; 2000 Jul; 20(7):872-3. PubMed ID: 10907983
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthetic and Natural Lipase Inhibitors.
    Bialecka-Florjanczyk E; Fabiszewska AU; Krzyczkowska J; Kurylowicz A
    Mini Rev Med Chem; 2018; 18(8):672-683. PubMed ID: 27484624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic lipase inhibitors from natural sources: unexplored potential.
    Birari RB; Bhutani KK
    Drug Discov Today; 2007 Oct; 12(19-20):879-89. PubMed ID: 17933690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy & Surgical Interventions Available for Obesity Management and Importance of Pancreatic Lipase Inhibitory Phytomolecules as Safer Anti-Obesity Therapeutics.
    Sukhdev S; Bhupender S; Singh KS
    Mini Rev Med Chem; 2017; 17(4):371-379. PubMed ID: 27468785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nepeta japonica Maximowicz extract from natural products inhibits lipid accumulation.
    Roh C; Jung U
    J Sci Food Agric; 2012 Aug; 92(10):2195-9. PubMed ID: 22311330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Water Extract of Pleurotus eryngii var. ferulae Prevents High-Fat Diet-Induced Obesity by Inhibiting Pancreatic Lipase.
    Jo KJ; Ghim J; Kim J; Lee H; Lee TG; Kim JI; Kim Y; Byun JW; Min BS; Son JS; Shim SG; Cheon WJ; Ryu SH
    J Med Food; 2019 Feb; 22(2):178-185. PubMed ID: 30657431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetilistat, a new lipase inhibitor for the treatment of obesity.
    Padwal R
    Curr Opin Investig Drugs; 2008 Apr; 9(4):414-21. PubMed ID: 18393108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia.
    Micić D; Ivković-Lazar T; Dragojević R; Jorga J; Stokić E; Hajduković Z
    Med Pregl; 1999; 52(9-10):323-33. PubMed ID: 10624380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic lipase inhibitors: The road voyaged and successes.
    Kumar A; Chauhan S
    Life Sci; 2021 Apr; 271():119115. PubMed ID: 33515565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity.
    Shi Y; Burn P
    Nat Rev Drug Discov; 2004 Aug; 3(8):695-710. PubMed ID: 15286736
    [No Abstract]   [Full Text] [Related]  

  • 20. Computational approaches for the discovery of natural pancreatic lipase inhibitors as antiobesity agents.
    Almasri IM
    Future Med Chem; 2020 Apr; 12(8):741-757. PubMed ID: 32212943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.